Disclosure of amyloid imaging results to research participants: has the time come?
about
Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research ResultsDevelopment of a process to disclose amyloid imaging results to cognitively normal older adult research participantsAmyloid imaging, risk disclosure and Alzheimer's disease: ethical and practical issues.Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment.Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit.Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward.Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.Recruiting to preclinical Alzheimer's disease clinical trials through registries.Amnestic MCI patients' experiences after disclosure of their amyloid PET result in a research context.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older Adults.From information to follow-up: Ethical recommendations to facilitate the disclosure of amyloid PET scan results in a research setting.Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosureDisclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review
P2860
Q27345258-15B0DAB4-7E00-4D25-AA5C-C259B3FEB6E6Q35595661-4AE79854-88ED-4813-A256-97E5A492F189Q35838385-F2BE975B-67A3-44D3-B800-0477D20A010AQ36883137-A416EAD5-6C06-4831-9F18-C11C65B9E581Q36885357-B1F11173-B7FE-496F-974F-11E7EEB136ABQ37670673-D88EC2CD-AA4E-4D0B-85C0-742880ADD885Q38219529-2E45658C-E5F1-43D7-9FE1-A710E80A45B0Q38821788-CDF39C5A-372B-423D-A783-C74F913293B4Q47115002-BBF23A4C-3823-4B95-AA1A-E3DEC57D91D5Q47587631-794BC54E-52CF-4962-B161-83E2B67C3E33Q47742387-1BA8B4AC-384A-4F0A-9622-C380780A205CQ55434541-C2FB0340-0B18-4864-BD15-570E80C3E4E7Q56373543-1183BF70-539C-446E-83A6-93549B570ADDQ57174282-35DEA612-F2FE-4758-9649-759A63A2EF5B
P2860
Disclosure of amyloid imaging results to research participants: has the time come?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Disclosure of amyloid imaging results to research participants: has the time come?
@en
Disclosure of amyloid imaging results to research participants: has the time come?
@nl
type
label
Disclosure of amyloid imaging results to research participants: has the time come?
@en
Disclosure of amyloid imaging results to research participants: has the time come?
@nl
prefLabel
Disclosure of amyloid imaging results to research participants: has the time come?
@en
Disclosure of amyloid imaging results to research participants: has the time come?
@nl
P2860
P1476
Disclosure of amyloid imaging results to research participants: has the time come?
@en
P2093
Jennifer H Lingler
P2860
P304
741-744.e2
P356
10.1016/J.JALZ.2012.09.014
P577
2013-02-13T00:00:00Z